Treatments in the pipeline
Find out more about potential MS treatments that have reported back with promising results from phase 2 and phase 3 trials.
It’s important that potential treatments for MS are tested in clinical trials to make sure that the safest and most effective treatments reach people with MS.
Clinical trials are usually completed in three phases before a treatment can be licensed. Around one in 10 potential treatments makes it through all three phases of clinical trials.
Find out about the potential treatments for:
- Alemtuzumab (Campath 1-H, Lemtrada)
- Stem cell therapy
08 Feb 2013
11 Oct 2012
10 Oct 2012
27 Sep 2012
24 Sep 2012